Her Daughter Died After Taking a Generic Version of a Lifesaving Drug. This Is What She Wants You to Know.

The article discusses the story of Hannah Goetz, a young woman who died after taking a generic version of tacrolimus, a crucial anti-rejection drug for transplant patients. Hannah received a double lung transplant at 17 due to cystic fibrosis complications and passed away at 21 in 2023. Her mother, Holly Goetz, shares her daughter's story to raise awareness about potential issues with generic tacrolimus and the FDA's drug approval processes. A pharmacist, Adam Cochrane, had identified concerns about the effectiveness of certain generic versions of the drug. Holly hopes that by sharing Hannah's experience, she can contribute to investigations and reforms regarding drug safety and accountability, as legal avenues to sue the generic manufacturer were unavailable. The article is part of a larger investigation by ProPublica into the FDA's handling of potentially risky drugs.